These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11683252)

  • 1. Carboxyalkylated histidine is a pH-dependent product of pegylation with SC-PEG.
    Wylie DC; Voloch M; Lee S; Liu YH; Cannon-Carlson S; Cutler C; Pramanik B
    Pharm Res; 2001 Sep; 18(9):1354-60. PubMed ID: 11683252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylating IFNs at his-34 improves the in vitro antiviral activity through the JAK/STAT pathway.
    Grace MJ; Cutler D
    Antivir Chem Chemother; 2004 Nov; 15(6):287-97. PubMed ID: 15646642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pH-dependent formation of PEGylated bovine lactoferrin by branched polyethylene glycol (PEG)-N-hydroxysuccinimide (NHS) active esters.
    Nojima Y; Iguchi K; Suzuki Y; Sato A
    Biol Pharm Bull; 2009 Mar; 32(3):523-6. PubMed ID: 19252310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the major positional isomer of pegylated interferon alpha-2b.
    Wang YS; Youngster S; Bausch J; Zhang R; McNemar C; Wyss DF
    Biochemistry; 2000 Sep; 39(35):10634-40. PubMed ID: 10978146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant protein hydrazides: application to site-specific protein PEGylation.
    Thom J; Anderson D; McGregor J; Cotton G
    Bioconjug Chem; 2011 Jun; 22(6):1017-20. PubMed ID: 21618993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, biology, and therapeutic implications of pegylated interferon alpha-2b.
    Youngster S; Wang YS; Grace M; Bausch J; Bordens R; Wyss DF
    Curr Pharm Des; 2002; 8(24):2139-57. PubMed ID: 12369859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Site-specific monoPEGylated interferon alpha2a mediated by microbial transglutaminase].
    Hui X; Cao W; Zhang D; Ge W; Li S; Li Y
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):750-762. PubMed ID: 32347069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific PEGylation at histidine tags.
    Cong Y; Pawlisz E; Bryant P; Balan S; Laurine E; Tommasi R; Singh R; Dubey S; Peciak K; Bird M; Sivasankar A; Swierkosz J; Muroni M; Heidelberger S; Farys M; Khayrzad F; Edwards J; Badescu G; Hodgson I; Heise C; Somavarapu S; Liddell J; Powell K; Zloh M; Choi JW; Godwin A; Brocchini S
    Bioconjug Chem; 2012 Feb; 23(2):248-63. PubMed ID: 22243664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylation prevents the N-terminal degradation of megakaryocyte growth and development factor.
    Guerra PI; Acklin C; Kosky AA; Davis JM; Treuheit MJ; Brems DN
    Pharm Res; 1998 Dec; 15(12):1822-7. PubMed ID: 9892464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal specificity of PEGylation of human bone morphogenetic protein-2 at acidic pH.
    Hu J; Sebald W
    Int J Pharm; 2011 Jul; 413(1-2):140-6. PubMed ID: 21539904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific PEGylation enhances the pharmacokinetic properties and antitumor activity of interferon beta-1b.
    Lee JI; Eisenberg SP; Rosendahl MS; Chlipala EA; Brown JD; Doherty DH; Cox GN
    J Interferon Cytokine Res; 2013 Dec; 33(12):769-77. PubMed ID: 23962003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of reducing agents for the PEGylation of recombinant human IL-10.
    Ambrogelly A; Cutler C; Paporello B
    Protein J; 2013 Jun; 32(5):337-42. PubMed ID: 23657524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural identification and biological activity of positional isomers of long-acting and mono-PEGylated recombinant human granulocyte colony-stimulating factor with trimeric-structured methoxy polyethylene glycol N-hydroxysuccinimidyl functional group.
    Son JP; Jun SW; Choi YK; Park HS; Son MK; Lee MY; Kang SH; Kang JS; Park YI
    Anal Biochem; 2012 Apr; 423(2):286-93. PubMed ID: 22244804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of mono- and di-PEGylate of exenatide and resolution of positional isomers of mono-PEGylates by preparative ion exchange chromatography.
    Nguyen NT; Lee JS; Yun S; Lee EK
    J Chromatogr A; 2016 Jul; 1457():88-96. PubMed ID: 27363735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein carboxyl amidation increases the potential extent of protein polyethylene glycol conjugation.
    Li S; Yang Z; Sun X; Tan Y; Yagi S; Hoffman RM
    Anal Biochem; 2004 Jul; 330(2):264-71. PubMed ID: 15203332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of random PEGylation reactions by means of high throughput screening.
    Maiser B; Dismer F; Hubbuch J
    Biotechnol Bioeng; 2014 Jan; 111(1):104-14. PubMed ID: 23939788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoform separation and structural identification of mono-PEGylated recombinant human growth hormone (PEG-rhGH) with pH gradient chromatography.
    Qin X; Li J; Li Y; Gan Y; Huang H; Liang C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():206-213. PubMed ID: 28153672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and biologic characterization of pegylated recombinant IFN-alpha2b.
    Grace M; Youngster S; Gitlin G; Sydor W; Xie L; Westreich L; Jacobs S; Brassard D; Bausch J; Bordens R
    J Interferon Cytokine Res; 2001 Dec; 21(12):1103-15. PubMed ID: 11798469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific PEGylation of human thyroid stimulating hormone to prolong duration of action.
    Qiu H; Boudanova E; Park A; Bird JJ; Honey DM; Zarazinski C; Greene B; Kingsbury JS; Boucher S; Pollock J; McPherson JM; Pan CQ
    Bioconjug Chem; 2013 Mar; 24(3):408-18. PubMed ID: 23350694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.